Myasthenia gravis syndrome associated with trimethadione.
D000927:Anticonvulsants / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced; D002648:Child; D004342:Drug Hypersensitivity / Q000209:etiology; D004832:Epilepsy, Absence / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008618:Mephobarbital / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000276:immunology; D009388:Neostigmine / Q000627:therapeutic use; D010080:Oxazoles / Q000009:adverse effects*; D011324:Primidone / Q000627:therapeutic use; D014293:Trimethadione / Q000009:adverse effects
D000927:Anticonvulsants; D010080:Oxazoles; D011324:Primidone; D009388:Neostigmine; D008618:Mephobarbital; D014293:Trimethadione